beyond spring pharma stock

BYSI stock quote history news and other vital information to help you with your stock trading and investing. BYSI stock are taking off on Wednesday following an important update regarding the firms lung cancer treatment.

Circling Back On Beyondspring Bysi Stock Seeking Alpha

Challenge the Old Buy and Hold.

. According to the issued ratings of 6 analysts in the last year the consensus rating for BeyondSpring stock is Hold based on the current 1 sell rating 3 hold ratings and 2 buy. BeyondSpring Inc a clinical stage biopharmaceutical company together with its subsidiaries focuses on the development of cancer therapies. Real time BeyondSpring Inc.

It had slid 27 in the six months through Tuesday. Lan Huang Beyond Springs co-founder chairman and chief executive officer. Ad Direxion Daily 3X PharmaMedical ETF.

They recently received or are about to receive 30mn. Get Beyondspring Inc BYSINASDAQ real-time stock quotes news price and financial information from CNBC. 10 2020 at 855 am.

BeyondSpring started at buy with 34 stock price target at Instinet Jan. Headquartered in New York City we are committed to raising the standard of care for cancer patients with first-in-class treatments that improve lives and clinical outcomes for. 20 2021 0222 PM.

Smart Technology for Confident Trading. Ad Our Strong Track Record Has Enabled Us To Become A Leader In Rare Disease. BYSI Q4 2021 Earnings Call Transcript.

We Are Well Positioned to Deliver Sustainable Top-Tier Growth Enhanced Shareholder Value. Why Are BeyondSprings Shares Plunging Today. Find the latest BeyondSpring Inc.

Events presentations. Joining us on todays call is Dr. We Are Well Positioned to Deliver Sustainable Top-Tier Growth Enhanced Shareholder Value.

Our Financial Advisors Offer a Wealth of Knowledge. Processa Pharmaceuticals has a consensus price target of. Ad Ensure Your Investments Align with Your Goals.

Lan Huang Beyond Springs co-founder chairman and chief executive officer. BeyondSpring is a global clinical-stage bio-pharmaceutical company developing innovative immuno-oncology cancer therapies with a robust pipeline from internal development and from. ET by Tomi Kilgore Opinion How to spot risky biotech companies and six to avoid now.

In China we own a 5797 interest in our. Shares of BeyondSpring BYSI -310 soared on Wednesday after the pharmaceutical company released promising clinical trial results for its investigational lung. Backed By 30 Years Of Experience.

Shares of BeyondSpring NASDAQ. Find a Dedicated Financial Advisor Now. Ad Our Strong Track Record Has Enabled Us To Become A Leader In Rare Disease.

BYSI stock price quote stock graph news analysis. Discover our most recent and upcoming events as well as download informative presentationsall right here. Find real-time BYSI - Beyondspring Inc stock quotes company profile news and forecasts from CNN Business.

Ad Explore the Latest Features Tools to Become a More Strategic Trader. Searching for Financial Security. Clinical stage biopharma companies BeyondSpring BYSI and CTI BioPharma CTIC have gained 49 and 45 in the pre-market respectively on below-average volume.

BYSI now has a market cap of 132mn a cash reserve of 93mn a small debt of 45mn and a large short interest of 23. Ramon Mohanlal MD PhD. The stock recently traded at 2711 compared with its Tuesday close at 963.

1 We own global rights to plinabulin in all countries except China. The service offers end-to-end research on both investing and trading ideas everyday and includes a 150-stock watchlist and two 40-stock model portfolios that are. BeyondSpring now will take its case to the.

Is a global biopharmaceutical company that is focused on developing immuno-oncology cancer therapies.

Stock Overview Beyondspring